# FDA Inspection 822657 - Agilera Pharma - March 12, 2013

Source: https://www.globalkeysolutions.net/records/fda_inspections/agilera-pharma/dfc65dfd-677a-4df0-8b6f-cac42b803e09
Source feed: FDA_Inspections

> FDA Inspection 822657 for Agilera Pharma on March 12, 2013. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 822657
- Company Name: Agilera Pharma
- Inspection Date: 2013-03-12
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1203671 - 2023-03-24](https://www.globalkeysolutions.net/records/fda_inspections/agilera-pharma/b8e1988b-243f-445a-899c-0298dbe40c7c)
- [FDA Inspection 1035520 - 2017-12-01](https://www.globalkeysolutions.net/records/fda_inspections/agilera-pharma/07ddeb21-8ce2-48cc-a842-3672191eafa9)
- [FDA Inspection 956443 - 2016-01-12](https://www.globalkeysolutions.net/records/fda_inspections/agilera-pharma/19c39ab7-3d17-49fd-9bee-f3dfb2d33b0e)
- [FDA Inspection 651395 - 2010-02-19](https://www.globalkeysolutions.net/records/fda_inspections/agilera-pharma/ee1d48af-d86d-453b-aa8e-315f37d82d34)

Company: https://www.globalkeysolutions.net/companies/agilera-pharma/3a658db3-8a35-4930-ba81-c106a13df5da

Office: https://www.globalkeysolutions.net/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c